Allogene Therapeutics, Inc. financial statements
Allogene Therapeutics, Inc.'s income statement, balance sheet and cash flow, annual and quarterly, each figure dated and linked to the filing it was read from.
FY2025
| Revenue | USD 0 | 10-K |
| Net income | −USD 190.89M | 10-K |
| Cash and equivalents | USD 51.69M | 10-Q |
| Total debt | USD 83.25M | EODHD |
Allogene Therapeutics, Inc. financials on 6ix · Allogene Therapeutics, Inc. on 6ix